| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |